Terms: = Ovarian cancer AND BTG1, P62324, 694, ENSG00000133639
49 results:
1. Carbohydrate quality, not quantity, linked to reduced colorectal cancer incidence and mortality in US populations: evidence from a prospective study.
Xiao Y; Xiang L; Jiang Y; Tang Y; Gu H; Wang Y; Peng L
BMC Med; 2024 Mar; 22(1):97. PubMed ID: 38443943
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasonographic diagnosis of adnexal masses: interobserver agreement in the interpretation of videos, using IOTA terminology.
Massobrio R; Mariani LL; Conti D; De Grandis T; Buonomo F; Badellino E; Novara L; Bounous VE; Perotto S; Mancarella M; Ferrero A; Biglia N; Fuso L
Arch Gynecol Obstet; 2024 Jan; 309(1):211-218. PubMed ID: 37789207
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of hyperthermic intraperitoneal chemotherapy plus cytoreductive surgery for advanced or recurrent ovarian cancer: a systematic evaluation and meta-analysis.
Li H; Liao LJ
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8135-8143. PubMed ID: 37750641
[TBL] [Abstract] [Full Text] [Related]
5. A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data.
Zhang Q; Ding Y; Shu Y; Chen J
BMC Cancer; 2023 Aug; 23(1):745. PubMed ID: 37568126
[TBL] [Abstract] [Full Text] [Related]
6. Combination of clinical and MRI features in diagnosing ovarian granulosa cell tumor: A comparison with other ovarian sex cord-gonadal stromal tumors.
Zhang J; Zhang Y; Guo Y
Eur J Radiol; 2023 Jan; 158():110593. PubMed ID: 36434968
[TBL] [Abstract] [Full Text] [Related]
7. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
[TBL] [Abstract] [Full Text] [Related]
8. Indications for cryopreservation and autotransplantation of ovarian tissue.
Gjeterud J; Kristensen SG; Fedder J
Tidsskr Nor Laegeforen; 2021 Oct; 141(2021-15):. PubMed ID: 34726041
[TBL] [Abstract] [Full Text] [Related]
9. Selection of eligible participants for screening for lung cancer using primary care data.
O'Dowd EL; Ten Haaf K; Kaur J; Duffy SW; Hamilton W; Hubbard RB; Field JK; Callister ME; Janes SM; de Koning HJ; Rawlinson J; Baldwin DR
Thorax; 2022 Sep; 77(9):882-890. PubMed ID: 34716280
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Denkert C; Seither F; Schneeweiss A; Link T; Blohmer JU; Just M; Wimberger P; Forberger A; Tesch H; Jackisch C; Schmatloch S; Reinisch M; Solomayer EF; Schmitt WD; Hanusch C; Fasching PA; Lübbe K; Solbach C; Huober J; Rhiem K; Marmé F; Reimer T; Schmidt M; Sinn BV; Janni W; Stickeler E; Michel L; Stötzer O; Hahnen E; Furlanetto J; Seiler S; Nekljudova V; Untch M; Loibl S
Lancet Oncol; 2021 Aug; 22(8):1151-1161. PubMed ID: 34252375
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with ovarian cancer.
Gallardo-Rincón D; Toledo-Leyva A; Bahena-González A; Montes-Servín E; Muñoz-Montaño W; Coronel-Martínez J; Oñate-Ocaña LF
Arch Med Res; 2020 Oct; 51(7):690-699. PubMed ID: 32768148
[TBL] [Abstract] [Full Text] [Related]
12. DNA Photocleavage in the Near-Infrared Wavelength Range by 2-Quinolinium Dicarbocyanine Dyes.
Ahoulou EO; Drinkard KK; Basnet K; St Lorenz A; Taratula O; Henary M; Grant KB
Molecules; 2020 Jun; 25(12):. PubMed ID: 32630496
[TBL] [Abstract] [Full Text] [Related]
13. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract] [Full Text] [Related]
14. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.
Phan K; Charlton O; Smith SD
Australas J Dermatol; 2020 Feb; 61(1):e28-e33. PubMed ID: 31261440
[TBL] [Abstract] [Full Text] [Related]
15. circMAN1A2 could serve as a novel serum biomarker for malignant tumors.
Fan CM; Wang JP; Tang YY; Zhao J; He SY; Xiong F; Guo C; Xiang B; Zhou M; Li XL; Li Y; Li GY; Xiong W; Zeng ZY
Cancer Sci; 2019 Jul; 110(7):2180-2188. PubMed ID: 31046163
[TBL] [Abstract] [Full Text] [Related]
16. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
[TBL] [Abstract] [Full Text] [Related]
17. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract] [Full Text] [Related]
18. [The prophylactic operational model integrated with occupational healthcare - Prophylactic of some types of cancers among women].
Wiszniewska M; Magnuska J; Lipińska-Ojrzanowska A; Pepłońska B; Hanke W; Kalinka J; Skręt-Magierło J; Zadrożny M; Walusiak-Skorupa J
Med Pr; 2018 Aug; 69(4):439-455. PubMed ID: 30038434
[TBL] [Abstract] [Full Text] [Related]
19. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
[TBL] [Abstract] [Full Text] [Related]
20. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract] [Full Text] [Related]
[Next]
